Genetic Driver Events in Premalignancy: LOH Validated for Marking the Risk of Oral Cancer

Webster K. Cavenee

doi:10.1158/1940-6207.CAPR-12-0220

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
Search More

Search for this keyword

Advanced Search

Perspectives

Genetic Driver Events in Premalignancy: LOH Validated for Marking the Risk of Oral Cancer

Webster K. Cavenee

Author's Affiliation: Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1940-6207.CAPR-12-0220 Published September 2012

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Additional Files

Related Article

The following article is available for this Perspective:
Loss of Heterozygosity (LOH) Profiles–Validated Risk Predictors for Progression to Oral Cancer
Lewei Zhang, Catherine F. Poh, Michele Williams, Denise M. Laronde, Ken Berean, Pamela J. Gardner, Huijun Jiang, Lang Wu, J. Jack Lee, and Miriam P. Rosin

PreviousNext

September 2012
Volume 5, Issue 9

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Genetic Driver Events in Premalignancy: LOH Validated for Marking the Risk of Oral Cancer

Message Subject (Your Name) has forwarded a page to you from Cancer Prevention Research

Message Body (Your Name) thought you would be interested in this article in Cancer Prevention Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Genetic Driver Events in Premalignancy: LOH Validated for Marking the Risk of Oral Cancer